FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

326364003: Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3699795016 Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699796015 Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699797012 Ethinyl estradiol 35 microgram and norgestimate 250 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4671011000052119 etinylestradiol 35 mikrogram och norgestimat 250 mikrogram, oral tablett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Is a Ethinylestradiol 35mcg+progestogen false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Hormone false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Ethinylestradiol false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Progesterone false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Estradiol false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Tablet false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Synthetic progestogen (substance) false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Is a Product containing ethinylestradiol and norgestimate (medicinal product) false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Norgestimate false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Is a Product containing estradiol in oral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mcg true Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mcg true Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Norgestimate false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Norgestimate false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) har täljarvärde som visar styrka 250 (qualifier value) false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has active ingredient Ethinylestradiol false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Ethinylestradiol false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) har täljarvärde som visar styrka 35 (qualifier value) false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) har täljarvärde som visar styrka 0.25 (qualifier value) false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) har täljarvärde som visar styrka 0.035 (qualifier value) false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Ethinylestradiol false Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Norgestimate false Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Is a Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) räkning av bas i aktiv ingrediens 2 (qualifier value) false Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Is a Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Plays role Contraceptive therapeutic role (role) true Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Ethinylestradiol true Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Ethinylestradiol true Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Norgestimate true Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Norgestimate true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start